Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy

Journal of Medical Virology

Volumn 83, Issue 12, 2011, Pages 2057-2065

  Fabbiani, Massimiliano ^a   Sali, Michela ^a   di Cristo, Valentina ^a   Pignataro, Giulia ^a   Prete, Valentina ^a   Farina, Salvatore ^a   D'Avino, Alessandro ^a   Manzara, Stefania ^a   Dal Verme, Lorenzo Zileri ^a   Silveri, Nicolò Gentiloni ^a   Cauda, Roberto ^a   Delogu, Giovanni ^a   Fadda, Giovanni ^a   di Giambenedetto, Simona ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Epidemiology; Pneumonia; Respiratory tract infection; Swine flu; Viral infection

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; INFLUENZA VACCINE; LACTATE DEHYDROGENASE; OSELTAMIVIR; POTASSIUM; SODIUM; VIRUS RNA;

2009 H1N1 INFLUENZA; ABDOMINAL PAIN; ACINETOBACTER BAUMANNII; ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHMA; ASYMPTOMATIC INFECTION; BILIRUBIN BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; ESCHERICHIA COLI; FEMALE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; ITALY; LACTATE DEHYDROGENASE BLOOD LEVEL; LENGTH OF STAY; LEUKOCYTOSIS; LEUKOPENIA; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALAISE; MALE; MONOCYTE; MYALGIA; NEUTROPHIL COUNT; NONHUMAN; OBSERVATIONAL STUDY; PNEUMONIA; POTASSIUM BLOOD LEVEL; PREGNANT WOMAN; PROSPECTIVE STUDY; PROTEUS MIRABILIS; RHINITIS; SEIZURE; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SORE THROAT; SPUTUM CULTURE; THORAX PAIN; THROAT CULTURE; THROMBOCYTE COUNT; VIRUS SHEDDING; VOMITING; WHEEZING;

ADULT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE; ITALY; MALE; MIDDLE AGED; NASOPHARYNX; PANDEMICS; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS;

INFLUENZA A VIRUS; SUIDAE;

EID: 80054856902     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22231     Document Type: Article

References (30)

1. Bassetti M, Parisini A, Calzi A, Pallavicini FM, Cassola G, Artioli S, Anselmo M, Pagano G, Rezza G, Viscoli C, Ligurian H1N1 Collaborative Group. 2011. Risk factors for severe complications of the novel influenza A (H1N1): Analysis of patients hospitalized in Italy. Clin Microbiol Infect 17: 247-250.
2. Bhattarai A, Villanueva J, Palekar RS, Fagan R, Sessions W, Winter J, Berman L, Lute J, Leap R, Marchbanks T, Sodha SV, Moll M, Xu X, Fry A, Fiore A, Ostroff S, Swerdlow DL, Pennsylvania Working Group. 2011. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak-Pennsylvania, May-June 2009. Clin Infect Dis 52: S102-S108.
3. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C, National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. 2009. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 361: 2507-2517.
4. Centers for Disease Control and Prevention. 2009. Swine influenza A (H1N1) infection in two children-Southern California, March-April, 2009. MMWR Morb Mortal Wkly Rep 58: 400-402.
5. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I. 2009. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 361: 2424-2435.
6. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM, Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
7. Di Giambenedetto S, Zileri DalVerme L, Sali M, Farina S, Di Cristo V, Manzara S, De Luca A, Pignataro G, Prosperi M, Di Franco A, Gentiloni Silveri N, Delogu G, Cauda R, Fabbiani M, Fadda G. 2011. Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection. Eur J Clin Microbiol Infect Dis 30: 541-549.
8. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA. 2009. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 302: 1880-1887.
9. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, Yardley IE. 2009. Mortality from pandemic A/H1N1 2009 influenza in England Public Health Surveillance Study. BMJ 339: b5213.
10. European Union Directive 2008/426/EC. 2008. Official Journal of the European Union 51: L159/46-90. Available at:. Last accessed on 26 May 2011.
11. Fabbiani M, Terrosi C, Martorelli B, Valentini M, Bernini L, Cellesi C, Cusi MG. 2009. Epidemiological and clinical study of viral respiratory tract infections in children from Italy. J Med Virol 81: 750-756.
12. Fabbiani M, Di Giambenedetto S, Sali M, Farina S, Sansonetti P, Tamburrini E, Dal Verme LZ, Delogu G, De Luca A, Kelvin D, Cauda R, Fadda G. 2011. Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients. Vaccine 29: 2836-2839.
13. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Centers for Disease Control Prevention. 2009. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58: 1-52.
14. Garcia-Garcia L, Valdespino-Gómez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, Cruz-Hervert P, Cano-Arellano B, Garcia-Anaya A, Ferreira-Guerrero E, Baez-Saldaña R, Ferreyra-Reyes L, Ponce-de-León-Rosales S, Alpuche-Aranda C, Rodriguez-López MH, Perez-Padilla R, Hernandez-Avila M. 2009. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: Case-control study in Mexico City. BMJ 339: b3928.
15. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
16. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, Pebody RG. 2011. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A (H1N1) 2009 infection in England and Scotland 2009-2010. Euro Surveill 16: pii:19763.
17. Istituto Superiore di Sanità. 2010. Influnet: Sorveglianza dell'influenza dalla stagione 2003-2004 alla 2009-2010. Available at: Last accessed on 26 May 2011.
18. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L, 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. 2009. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361: 1935-1944.
19. Laguna-Torres VA, Benavides JG. 2009. Infection and death from influenza A H1N1 virus in Mexico. Lancet 374: 2032-2033.
20. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group. 2009. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 302: 1896-1902.
21. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. 2010. Incidence of 2009 pandemic influenza A H1N1 infection in England: A cross-sectional serological study. Lancet 375: 1100-1108.
22. Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE, Jr., Williams JV, Melendi GA, Polack FP. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 17: 195-199.
23. Neumann G, Noda T, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
24. Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E. 2011. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 29: 2613-2618.
25. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA, INER Working Group on Influenza. 2009. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680-689.
26. Rizzo C, Rota MC, Bella A, Giannitelli S, De Santis S, Nacca G, Pompa MG, Vellucci L, Salmaso S, Declich S. 2010. Response to the 2009 influenza A (H1N1) pandemic in Italy. Euro Surveill 15: pii:19744.
27. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, Louie J, Doyle TJ, Crockett M, Lynfield R, Moore Z, Wiedeman C, Anand M, Tabony L, Nielsen CF, Waller K, Page S, Thompson JM, Avery C, Springs CB, Jones T, Williams JL, Newsome K, Finelli L, Jamieson DJ, Pandemic H1N1 Influenza in Pregnancy Working Group. 2010. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA 303: 1517-1525.
28. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, Ouhoummane N, Willison DJ, Rouleau I, Petric M, Fonseca K, Drews SJ, Rebbapragada A, Charest H, Hamelin ME, Boivin G, Gardy JL, Li Y, Kwindt TL, Patrick DM, Brunham RC, Canadian SAVOIR Team. 2010. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: Four observational studies from Canada. PLoS Med 7: e1000258.
29. Suryaprasad A, Morgan OW, Peebles P, Warner A, Kerin TK, Esona MD, Bowen MD, Sessions W, Xu X, Cromeans T, Dawood F, Shim T, Menon M, Verani JR, Erdman D, Lindstrom S, Fonseca VP, Fry AM, Olsen SJ. 2011. Virus detection and duration of illness among patients with 2009 pandemic influenza A (H1N1) virus infection in Texas. Clin Infect Dis 52: S109-S115.
30. World Health Organization. 2009. Protocol of real-time RT-PCR for influenza A (H1N1), 28 April 2009. Available at: Last accessed on 26 May 2011.